在维尔姆斯瘤中,PD-L1表达通过微RNA处理,Wnt/β-catenin信号传递和化疗来调节
Kavita Desai1,2, Patricia D B Tiburcio3, Austin Warne3
1Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA.
bioRxiv : the preprint server for biology
|December 16, 2024
概括
在威尔姆斯瘤中,PD-L1被上调,这是一种儿科癌,特别是在化疗后. 遗传突变和Wnt/β-catenin信号也会增加PD-L1,这表明儿科免疫瘤学中的新治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 免疫检查点抑制剂在成人癌症中有效,但在儿童癌症中效果较差.
- 像PD-L1这样的免疫检查点蛋白的调节在儿科癌症中了解得很少.
研究的目的:
- 为了研究PD-L1在威尔姆斯瘤中的调节,这是一种常见的儿科癌.
- 确定影响儿科癌症PD-L1表达的因素,以确定潜在的治疗策略.
主要方法:
- 分析了威尔姆斯瘤样本中的PD-L1表达,包括化疗暴露的样本.
- 利用儿童癌症细胞系研究化疗药物对PD-L1.1的体外影响.
- 研究了CTNNB1和DROSHA和PD-L1水平中的突变之间的相关性.
- 研究了Wnt/β-catenin信号激活和DROSHA/DICER1敲击对PD-L1表达的影响.
- 评估了成人癌症中的DICER1变异,涉及免疫基因表达和对检查点抑制剂的反应.
主要成果:
- 在威尔姆斯瘤的不同亚组中,PD-L1被上调,特别是在暴露于化疗的标本中.
- 化疗药物在儿童癌症细胞系中增加了体外PD-L1表达.
- 在CTNNB1和DROSHA中的突变与更高的PD-L1水平相关.
- 在体外,Wnt/β-catenin信号激活和DROSHA/DICER1倒置增加了PD-L1.
- 成人癌症中DICER1的改变与免疫基因特征和对免疫检查点抑制剂的反应改善有关.
结论:
- 已经确定了在威尔姆斯瘤中调节PD-L1的临床和生物因素.
- 研究结果表明,这可能是儿科免疫瘤学的精密治疗方法.
- 了解儿科癌症中的PD-L1调节对于提高治疗疗效至关重要.
相关概念视频
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K


